BackGeneDx Holdings Overview
GeneDx Holdings Corp - Ordinary Shares - Class A

GeneDx Holdings Target Price

Analysts' average 12-month price target for GeneDx Holdings is $78.

Get informed when a big investor buys or sells

+ Follow

Share Price

$85.99

Average Target Price

$77.759.6% downside

8 analysts in the last 4 months

High: $90 | Low: $63

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-04Canaccord GenuityKyle Mikson$904.7% upsideOpen
2026-06-29Guggenheim$7413.9% downsideOpen
2026-06-23Piper SandlerDavid Westenberg$6326.7% downsideOpen
2026-05-05Craig-HallumBill Bonello$851.2% downsideOpen
2026-05-05BTIG$904.7% upsideOpen
2026-05-05Guggenheim$7018.6% downsideOpen
2026-05-05Canaccord GenuityKyle Mikson$7512.8% downsideOpen
2026-05-05Wells FargoBrandon Couillard$7512.8% downsideOpen
2026-04-20Canaccord Genuity$10016.3% upsideOpen
2026-02-24BTIGMark Massaro$17097.7% upsideOpen
2026-02-24Piper SandlerDavid Westenberg$13051.2% upsideOpen
2026-02-23Jefferies$15074.4% upsideOpen
2025-12-22Canaccord Genuity$17097.7% upsideOpen
2025-12-15Wells Fargo$15580.3% upsideOpen
2025-12-12BTIG$200132.6% upsideOpen
2025-10-29BTIG$16591.9% upsideOpen
2025-10-29Canaccord Genuity$16086.1% upsideOpen
2025-10-29Guggenheim$17097.7% upsideOpen
2025-10-20Canaccord Genuity$15580.3% upsideOpen
2025-08-04Piper Sandler$12039.6% upsideOpen
2024-10-24Craig-HallumBill Bonello$7018.6% downsideOpen
2024-08-27Wells FargoBrandon Couillard$3460.5% downsideOpen
2024-07-31BTIGMark Massaro$4547.7% downsideOpen
2024-07-10Craig-HallumBill Bonello$4350% downsideOpen
2024-06-26BTIGMark Massaro$3559.3% downsideOpen
2024-06-03JefferiesTycho Peterson$2175.6% downsideOpen
2024-04-30BTIGMark Massaro$1977.9% downsideOpen

GeneDx Holdings (WGS) FAQ

The latest target price for WGS is $78. Investors often review this figure alongside GeneDx Holdings's historical trend and sector peers before judging valuation or financial health.

GeneDx Holdings trades near $85.99 while the consensus target sits at $78 (9.6% downside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting WGS's target price ($78), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack GeneDx Holdings's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.